DE69625182D1 - Immunoglobuline der g-klasse zur lokalen behandlung von hautentzündungen - Google Patents

Immunoglobuline der g-klasse zur lokalen behandlung von hautentzündungen

Info

Publication number
DE69625182D1
DE69625182D1 DE69625182T DE69625182T DE69625182D1 DE 69625182 D1 DE69625182 D1 DE 69625182D1 DE 69625182 T DE69625182 T DE 69625182T DE 69625182 T DE69625182 T DE 69625182T DE 69625182 D1 DE69625182 D1 DE 69625182D1
Authority
DE
Germany
Prior art keywords
dermatitis
class
immunoglobuline
skin inflammation
local treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69625182T
Other languages
English (en)
Other versions
DE69625182T2 (de
DE69625182T3 (de
Inventor
Simone Claudio De
Pietro Bruschi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actial Farmaceutica Ltda
Original Assignee
VSL Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11403139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69625182(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by VSL Pharma Ltd filed Critical VSL Pharma Ltd
Publication of DE69625182D1 publication Critical patent/DE69625182D1/de
Publication of DE69625182T2 publication Critical patent/DE69625182T2/de
Application granted granted Critical
Publication of DE69625182T3 publication Critical patent/DE69625182T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69625182T 1995-03-14 1996-03-12 Immunoglobuline der g-klasse zur lokalen behandlung von hautentzündungen Expired - Lifetime DE69625182T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT95RM000154A IT1278052B1 (it) 1995-03-14 1995-03-14 Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per
ITRM950154 1995-03-14
PCT/IT1996/000047 WO1996028186A1 (en) 1995-03-14 1996-03-12 Use of g class immunoglobulins for the topical treatment of atopic dermatitis

Publications (3)

Publication Number Publication Date
DE69625182D1 true DE69625182D1 (de) 2003-01-16
DE69625182T2 DE69625182T2 (de) 2003-11-20
DE69625182T3 DE69625182T3 (de) 2006-08-24

Family

ID=11403139

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69625182T Expired - Lifetime DE69625182T3 (de) 1995-03-14 1996-03-12 Immunoglobuline der g-klasse zur lokalen behandlung von hautentzündungen

Country Status (12)

Country Link
US (2) US6410019B1 (de)
EP (1) EP0814837B2 (de)
JP (1) JP3939346B2 (de)
KR (1) KR19980702515A (de)
AT (1) ATE228854T1 (de)
CA (1) CA2213500C (de)
DE (1) DE69625182T3 (de)
DK (1) DK0814837T4 (de)
ES (1) ES2187635T5 (de)
IT (1) IT1278052B1 (de)
PT (1) PT814837E (de)
WO (1) WO1996028186A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059428A1 (en) * 1993-02-26 2003-03-27 Boris Skurkovich Treatment of autoimmune diseases
US7297480B2 (en) * 2001-06-28 2007-11-20 Dermtech International Method for detection of melanoma
US7183057B2 (en) * 2004-03-31 2007-02-27 Dermtech International Tape stripping methods for analysis of skin disease and pathological skin state
AU2008247502A1 (en) * 2007-05-04 2008-11-13 Dermtech International Diagnosis of melanoma by nucleic acid analysis
CN102089444A (zh) 2008-05-14 2011-06-08 德玛泰克国际公司 利用核酸分析方法来诊断黑素瘤和太阳能雀斑
EP2977469A1 (de) * 2008-08-28 2016-01-27 Dermtech International Bestimmung der altersbereiche von hautproben
CN103002907A (zh) * 2010-04-23 2013-03-27 普若拜特有限公司 湿疹治疗
EP3752645A4 (de) 2018-02-14 2022-04-13 Dermtech, Inc. Neue gen-klassifikatoren und deren verwendung bei nicht-melanom-hautkrebs
US11578373B2 (en) 2019-03-26 2023-02-14 Dermtech, Inc. Gene classifiers and uses thereof in skin cancers
WO2022216027A1 (ko) * 2021-04-07 2022-10-13 아주대학교산학협력단 산화된 면역글로불린을 유효성분으로 포함하는 면역조절 기능 이상 관련 질환 예방 또는 치료용 약학적 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2610854A1 (de) * 1976-03-15 1977-09-22 Biotest Serum Institut Gmbh Galenische immunglobulinzubereitung
DE3378890D1 (en) * 1983-06-07 1989-02-16 Stolle Res & Dev Deodorant containing bacterial antibodies
US5141742A (en) * 1986-02-07 1992-08-25 Oncogen Vaccines against melanoma
AU3687489A (en) * 1988-07-22 1990-02-19 Ciro's Touch, Ltd. Compositions and methods for treating skin conditions and promoting wound healing
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
FR2669538B1 (fr) * 1990-11-28 1995-03-03 Fondation Nale Transfusion San Utilisation d'immunoglobulines administrees localement dans le traitement des infections epitheliales.
CA2153661A1 (en) * 1993-01-12 1994-07-21 Anthony George Gristina Methods and compositions for the direct concentrated delivery of passive immunity
JP3193205B2 (ja) * 1993-08-09 2001-07-30 日本臓器製薬株式会社 好酸球増多抑制剤

Also Published As

Publication number Publication date
EP0814837B2 (de) 2006-02-22
JPH11501915A (ja) 1999-02-16
JP3939346B2 (ja) 2007-07-04
EP0814837B1 (de) 2002-12-04
ES2187635T3 (es) 2003-06-16
ITRM950154A0 (it) 1995-03-14
ITRM950154A1 (it) 1996-09-14
EP0814837A1 (de) 1998-01-07
WO1996028186A1 (en) 1996-09-19
CA2213500A1 (en) 1996-09-19
DK0814837T3 (da) 2003-03-31
US20020192276A1 (en) 2002-12-19
US6410019B1 (en) 2002-06-25
DK0814837T4 (da) 2006-05-29
IT1278052B1 (it) 1997-11-17
CA2213500C (en) 2010-01-26
US7217416B2 (en) 2007-05-15
KR19980702515A (ko) 1998-07-15
ES2187635T5 (es) 2006-09-01
DE69625182T2 (de) 2003-11-20
ATE228854T1 (de) 2002-12-15
DE69625182T3 (de) 2006-08-24
PT814837E (pt) 2003-04-30

Similar Documents

Publication Publication Date Title
ATE214933T1 (de) Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten
DE69428268T2 (de) Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthma
DE69733826D1 (de) Behandlung von leukocyten durch photopheresis
DE69617469T2 (de) Behandlung von multipler sklerose
KR970705990A (ko) 피부 질환 치료용 조성물(Compositions for the Treatment of Skin Disorders)
DE69418601D1 (de) Guanidinderivate mit therapeutischer wirkung
DE69029100D1 (de) Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris
BR9407824A (pt) Processos para tratar e para interromper e reverter alopécia androgência e para diminuir o nível de 5 &-di-hidro-testosterona no escalpo humano
DE69625182D1 (de) Immunoglobuline der g-klasse zur lokalen behandlung von hautentzündungen
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
DE69431476D1 (de) Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
FR2556348B1 (fr) Retinoides, leur preparation et leurs utilisations therapeutiques, notamment pour le traitement des neoplasies, de l'acne et du psoriasis
TR199700694T1 (xx) D vitamini t�revlerinin dermotolojik kullan�m�.
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
DE69424563D1 (de) Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis
DE69129693D1 (de) Verwendung von nickel und bromide ionen für die behandlung von psoriasis
RU94041246A (ru) Способ лечения псориаза
DE69433923D1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
DE59305285D1 (de) Transdermales therapeutisches system mit pentylentetrazol als wirkstoff
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
GEU1998400Y (en) Ointment “Topokril” for Treating of Dermatitis

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: ACTIAL FARMACEUTICA LDA., FUNCHAL, MADEIRA, PT